GOSS Total Utang marang Modal Gossamer Bio Corp.
Gossamer Bio, Inc. (GOSS) develops innovative treatments for inflammatory pathologies, leveraging a robust scientific foundation. The debt-to-equity ratio reflects the market reaction to such data, where the value of 0.00 captures the metric level. Risks are being mitigated by expanding patient cohorts in trials, although management is currently adjusting the overall development strategy.
Rincian analitis lan laporan data perusahaan Gossamer Bio Corp. (GOSS)
- rega lan prakiraan konsensus rega:
- data kapitalisasi pasar:
- data kapitalisasi buku:
- data utang lan likuiditas:
Utang marang Ekuitas Gossamer Bio, Inc.|GOSS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Gossamer Bio, Inc.|GOSS - Gunggung utang perusahaan|Utang marang nilai buku Gossamer Bio|GOSS - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Gossamer Bio
Analisis komprehensif perusahaan:GOSS - Gossamer Bio
The total debt-to-equity ratio measures the proportion of borrowed funds within the asset financing structure. Gossamer Bio, Inc. (GOSS) expenditures on complex biomaterial logistics during clinical trials may impact its credit load. By analyzing the degree of equity leverage on GURU.Markets, an investor gains a real-time assessment of the balance of liabilities. This trend captures the extent to which development depends on external loans, which ultimately determines the overall financial stability of the issuer.
Pesaing utama
Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas kalvista.com (KALV)|SEPN: Total Utang marang Modal|Utang marang Modal Pieris Pharma PVLA|Total Utang marang Modal SVRA|RIGL: Rasio Utang marang Modal|Utang marang Ekuitas ANAB|ATXS (astriatx.com) - Utang marang Modal|ENGN: Utang marang Ekuitas|Koefisien Total Utang marang Modal RAPT|JBIO (Aerovate Therapeutics Inc) - Utang marang Ekuitas|Koefisien Total Utang marang Modal Aclaris Therapeutics, Inc (ACRS)|Total Utang marang Modal KYTX (Kyverna Therapeutics)|tizianalifesciences.com - Total Utang marang Modal|CABA: Utang marang Ekuitas|VTYX - Rasio Total Utang marang Ekuitas|Total Utang marang Modal THTX|AVTX (Avalo Therapeutics Inc) - Utang marang Modal|ELDN - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi agenusbio.com (AGEN)|Climb Bio (CLYM) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Zura Bio Ltd (ZURA)|Total Utang marang Modal aTyr ATYR|Utang marang Ekuitas Adagene Inc ADAG|Total Utang marang Modal IMA (Ikena Oncology, Inc.)|STTK: Koefisien Total Utang marang Modal|Utang marang Ekuitas EQ|Utang marang Modal Connect Biopharma Holdings Limited|IMUX - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Atara Biotherapeutics Inc|IFRX (InflaRx N.V.) - Total Utang marang Modal|Koefisien Total Utang marang Modal XFOR (x4pharma.com)|ACET - Utang marang Ekuitas|Rasio Utang marang Ekuitas Celularity Inc CELU|INMB: Total Utang marang Modal|Barinthus Biotherapeutics Corp (BRNS) - Rasio Total Utang marang Ekuitas|Kezar Life Sciences - Rasio Total Utang marang Ekuitas|sabbiotherapeutics.com (SABS) - Koefisien Total Utang marang Modal|Akari Therapeutics Plc - Total Utang marang Modal|Rasio Utang marang Modal ENLV|Q32 Bio Inc. - Utang marang Ekuitas|Utang marang Modal GOVX (GeoVax Corp)|Utang marang Ekuitas EDSA|ibioinc.com - Koefisien Total Utang marang Modal|Utang marang Ekuitas CARM (Carisma Tx)|XTLB: Koefisien Total Utang marang Modal|Utang marang Ekuitas boltbio.com (BOLT)|HCW Biologics (HCWB) - Utang Agregat marang Ekuitas|APVO - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi AIM ImmunoTech, Inc.|Total Utang marang Modal ADTX|Total Utang marang Modal GRI (GRI Bio Inc)|Utang marang Ekuitas XORTX|Vyome Therapeutics - Rasio Kabeh Utang marang Dana Pribadi|REVB: Utang marang Ekuitas|INDP - Rasio Total Utang marang Ekuitas|SCNI: Total Utang marang Modal|Total Utang marang Modal CalciMedica|AFMD - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Allakos Therapeutics|HOOK (HOOKIPA Pharma Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal IGMS (igmbio.com)|iTeos Therapeutics, Inc. - Utang marang Ekuitas|Ocean Biomedical Inc - Rasio Total Utang marang Ekuitas|TCBP: Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas